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Antigen Receptor Galaxy: A User-Friendly, Web-Based Tool
for Analysis and Visualization of T and B Cell Receptor
Repertoire Data
Hanna IJspeert,*,1 Pauline A. van Schouwenburg,*,1 David van Zessen,*,†
Ingrid Pico-Knijnenburg,* Andrew P. Stubbs,†,1 and Mirjam van der Burg*,1
Antigen Receptor Galaxy (ARGalaxy) is a Web-based tool for analyses and visualization of TCR and BCR sequencing data of 13
species. ARGalaxy consists of four parts: the demultiplex tool, the international ImMunoGeneTics information system (IMGT)
concatenate tool, the immune repertoire pipeline, and the somatic hypermutation (SHM) and class switch recombination (CSR)
pipeline. Together they allow the analysis of all different aspects of the immune repertoire. All pipelines can be run independently
or combined, depending on the available data and the question of interest. The demultiplex tool allows data trimming and
demultiplexing, whereas with the concatenate tool multiple IMGT/HighV-QUEST output files can be merged into a single file.
The immune repertoire pipeline is an extended version of our previously published ImmunoGlobulin Galaxy (IGGalaxy) virtual
machine that was developed to visualize V(D)J gene usage. It allows analysis of both BCR and TCR rearrangements, visualizes
CDR3 characteristics (length and amino acid usage) and junction characteristics, and calculates the diversity of the immune
repertoire. Finally, ARGalaxy includes the newly developed SHM and CSR pipeline to analyze SHM and/or CSR in BCR
rearrangements. It analyzes the frequency and patterns of SHM, Ag selection (including BASELINe), clonality (Change-O),
and CSR. The functionality of the ARGalaxy tool is illustrated in several clinical examples of patients with primary immunode-
ficiencies. In conclusion, ARGalaxy is a novel tool for the analysis of the complete immune repertoire, which is applicable to many
patient groups with disturbances in the immune repertoire such as autoimmune diseases, allergy, and leukemia, but it can also be used
to address basic research questions in repertoire formation and selection. The Journal of Immunology, 2017, 198: 4156–4165.
E
very T and B cell expresses a unique Ag receptor, called
TCR or BCR, respectively. Ag receptors are generated
during B and T cell development by recombination of one
V, one D, and one J gene on the Ag receptor loci. A large diversity
of Ag receptors is created by making different combination of V,
D, and J genes and by removal of nucleotides (deletions) and
insertion of nontemplated (N) nucleotides at the junctional regions.
This large diversity in Ag receptors is crucial for a proper immune
defense against all different pathogens. After V(D)J recombination,
T and B cells that express a functional Ag receptor on their mem-
brane migrate to the periphery where they can encounter an Ag.
After Ag recognition, B cells migrate to the germinal center
where they acquire somatic hypermutations (SHM) in the V region
of the BCR, which change the affinity for their Ag. B cells with
increased affinity are selected for survival, whereas cells with
decreased affinity undergo apoptosis. Additionally, B cells can
undergo class switch recombination (CSR) to replace the constant
genes of their BCR, which changes the effector function of the Ab
or Ig molecule, that is, the secreted form of the BCR.
Sequencing of Ag receptor genes has been done for many years to
study the Ag receptor repertoire development in health and disease
and to aid the diagnosis of, for example, leukemia and lymphomas.
More recently, next-generation sequencing techniques have opened
new doors for the analysis of the Ag receptor repertoire. Previous
studies described 100–1000 reads at most, whereas now a single
run can provide up to 1 million immune receptor sequences. This
allows for more in-depth studies, but it also makes data analysis
much more complex. Therefore, there is need for simple and robust
pipelines that provide the analysis and visualization of all different
aspects of the Ag receptor repertoire (1).
A variety of programs have been developed for high-throughput
V(D)J gene assignment, as well as CDR3 identification and
characterization, including international ImMunoGeneTics infor-
mation system (IMGT)/HighV-QUEST, IgBLAST, JoinSolver, Ig
analysis tool (IgAT), and Vidjil (2–6). Other tools can be used to
define clones in the repertoire (Change-O) (4) or analyze Ag se-
lection (IgAT and BASELINe) (5, 7) or CSR (8). We have pre-
viously published the ImmunoGlobulin Galaxy (IGGalaxy) tool
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that allows analysis of V, D, and J gene usage and CDR3 length
(9). In this study, we describe the Antigen Receptor Galaxy
(ARGalaxy), which is an open-source, user-friendly tool for
analysis, visualization, and reporting of immune receptor reper-
toire data. The advantage of this tool is that it combines the
analysis of V(D)J genes, CDR3, clonotypes, diversity, SHM, Ag
selection, and CSR all in a single tool.
Materials and Methods
Patient samples
Peripheral blood was used from one ARTEMIS-deficient patient
(ARTEMIS-13) (10), one UNG-deficient patient (UNG-2) (11), six XLF-
deficient patients (XLF-1, XLF-5, XLF6-1, XLF6-2, and XLFP1, XLFP2)
(12), four XRCC4-deficient patients (XRCC4-1, XRCC4-2, XRCC4-3, and
XRCC4-4) (13), three LIG4-deficient patients (Ligase-IV-5, Ligase-IV-6,
and Ligase-IV-7) (13), one NBS-deficient patient (NBS-4) (14), patients
AT3 and AT4 (15) with ataxia telangiectasia (AT), and one patient suf-
fering from chronic lymphocytic leukemia. Samples were obtained
according to the guidelines of the Medical Ethics Committees of the
Erasmus MC.
Repertoire sequencing using next-generation sequencing
For the analysis of the naive BCR repertoire, CD19+, CD272, IgD+, CD32
naive B cells were FACS sorted. DNAwas isolated using direct lysis (16),
and IGH rearrangements were amplified and sequenced using Roche 454
sequencing as previously described (14, 15). In short, IGH rearrangements
were amplified using a multiplex PCR using the forward VH1-6 FR1 and
reverse JH consensus BIOMED-2 primers (17). These PCR products were
purified and sequenced using Roche 454 sequencing as previously de-
scribed (14, 15). In short, PCR products were purified by gel extraction
(Qiagen, Valencia, CA) and Agencourt AMPure XP beads (Beckman
Coulter, Fullerton, CA). Subsequently, the concentration of the PCR
product was measured using the Quant-iT PicoGreen dsDNA assay
(Invitrogen, Carlsbad, CA). The purified PCR products were sequenced on
the 454 GS junior instrument using the Lib-A kit according the manu-
facturer’s recommendations. For the analysis of the Ag selected BCR
repertoire, RNA was isolated from total PBMCs and RNA was extracted
using the GenElute mammalian total RNA miniprep kit (Sigma-Aldrich,
St. Louis, MO). Subsequently, cDNAwas made using random primers and
amplified using VH1-6 FR1 forward primers and either the CgCH (18) or
the IGHA (19) reverse primer. The product was purified and sequenced as
described above, using the Lib-A V2 kit for sequencing.
Data analysis
Sequences were demultiplexed based on their multiplex identifier sequence
and 20–40 nt were trimmed from both sides to remove the primer sequence
using the demultiplex tool. FASTA files were analyzed in IMGT/HighV-
QUEST (selection of IMGT reference directory set: F+ORF+in-frame P
with all alleles; search for insertions and deletions: yes; parameters for
IMGT/Junction Analysis: default) (2). Subsequently, the IMGT/HighV-
QUEST output files were analyzed in the immune repertoire pipeline
and/or the SHM and CSR pipeline from ARGalaxy. We used the following
data from healthy donors—NWK237 naive MID8 (Fig. 5A, 5C); NWK237
Ag selected (Fig. 5A–C); NWK276, NWK279, NWK180, NWK245,
NWK301, NWK299, NWK3, NWK302, NWK162 (Fig. 5D, 5E); NWK31,
NWK54, NWK65, NWK56 (Fig. 6A); NWK53, NWK43, NWK303,
NWK383, NWK214 (Fig. 6B); Perio34, Perio37, NWK237, NWK397,
NWK380, NWK299, NWK378, NWK377 (Fig. 6C)—from our previously
published control data set (ENA PRJEB15348) (20). We used the immune
repertoire pipeline to analyze the data from Fig. 5 using productive
rearrangements and the clonotype definition (V, J, nucleotide CDR3)
except for Fig. 5B, where we did not remove duplicates based on the
clonotype definition. The SHM and CSR pipeline was used to analyze the
data for Fig. 6 using the following settings: sequence start at FR1, pro-
ductive, remove uniques, do not remove duplicates, .70% class, and
.70% subclass.
Change-O
In the SHM and CSR pipeline Change-O (4) has been implemented for
assigning clonal relationships. For calculations the nucleotide hamming
distance substitution model was used with a complete distance of maximal
three. For clonal assignment the first genes were used, and the distances
were not normalized. In case of asymmetric distances, the minimal dis-
tance was used. With these settings clones are defined as sequences with
the same Vand J gene and junction length and a maximal of 3 nt difference
between all CDR3 nucleotide sequences within a clone.
BASELINe
To determine the selection strength of the CDR and FR regions, the
BASELINe tool was integrated into the SHM and CSR pipeline with the
following settings: selection statistics: focused; SHM targeting model:
human trinucleotide; custom boundaries: when the filter “sequence start at:
leader” is chosen: 1:26:38:55:65:104:- or 27:27:38:55:65:104:- for the
remaining options in the “sequence start at” filter. Please note that this
means that when choosing the option CDR1 or FR2 in the sequence starts
at filter, the CDR1 and FR2 are still included for the baseline calculations
(7, 21).
Validation
The demultiplex tool, concatenate tool, the Immune Repertoire pipeline,
and SHM and CSR pipeline are checked manually using Excel.
Results
ARGalaxy provides a flexible, user-friendly tool that allows
analysis of the complete immune repertoire. It is developed on the
Galaxy platform and composed of a combination of Python and R
components together, creating a straightforward data flow (22, 23).
ARGalaxy consists of four parts: one tool for demultiplexing and
sequence trimming of .sff files (the demultiplex tool); one tool that
allows concatenating IMGT/High V-QUEST files (the IMGT
concatenate tool); the immune repertoire pipeline, which allows
for the study of V(D)J gene usage, CDR3 and junction charac-
teristics, and the diversity of all immune receptor genes; and fi-
nally the SHM and CSR pipeline for the analysis of SHM and Ag
selection in IGH, IGK, and IGL rearrangements, and CSR in the
IGH rearrangements. All parts of the tool can be run indepen-
dently or combined, depending on the available data and the
question of interest. A complete overview of the workflow and
output information of ARGalaxy can be found in Fig. 1. ARGalaxy
can be installed on an existing Galaxy server through the Galaxy
Tool Shed (https://toolshed.g2.bx.psu.edu/repository?repository_
id=2e457d63170a4b1c&changeset_revision=28fbbdfd7a87) (24),
and it is freely available via https://bioinf-galaxian.erasmusmc.nl/
argalaxy/ (Fig. 2A). Tutorials and detailed descriptions for all
filtering options and output data can be found on the front page
of the Web site. Additionally, at the bottom of each page de-
tailed descriptions of the filters and the results on that page can
be found.
The demultiplex tool
The demultiplex tool allows demultiplexing of .sff files based on
the Roche multiplex identifier (MID) tags (Fig. 2B). This tool
allows the user to select the appropriate MID tags, assign a sample
name, and choose the amount of nucleotides to be trimmed from
all sequences on either or both sides. It is possible to search for
MID tags on either the 39 or 59 end and to adjust the number of
allowed mismatches or the amount of partial overlap allowed
between MID tags. This pipeline is based on freely available
tools, including sff2fastq (https://github.com/indraniel/sff2fastq),
FASTX-Toolkit software (http://hannonlab.cshl.edu/fastx_toolkit/
commandline.html), and the FastQC tool to check the quality
of your data (http://www.bioinformatics.babraham.ac.uk/projects/
fastqc/). Upon demultiplexing, data will be downloadable in
FASTA and FASTQ formats (Fig. 2C). The FASTA files can be
run in the immune repertoire pipeline, or they can be uploaded to
IMGT/HighV-QUEST (2).
Data trimming using the demultiplex tool is an essential step in
data preparation, as obtained reads often consist of template-
specific sequences flanked by sequence tags or barcodes
that are not template-specific but used to multiplex samples
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or are platform-specific. Additionally, Ag receptor rearrangements
are frequently amplified with family or consensus primers. These
primers are designed to limit the number of primers necessary to
cover the high number of genes by allowing mismatches in primer
binding. When including either the nontemplate-specific or the
template-specific primer regions in downstream analysis, this can
highly influence results. For example, the median percentage SHM
in Ag-experienced B cells of healthy donors in trimmed data is
significantly decreased compared with untrimmed data (Fig. 2D).
Additionally, when the primer or tag regions contain stop codons,
transcripts can be unfairly categorized as unproductive, also
skewing analysis results.
The concatenate tool
The concatenate tool allows combining of multiple .txz files (as
downloaded from IMGT/High V-QUEST) into a single .txz file
(Fig. 3A). This can for instance be used for combining sequencing
data from a single patient that are obtained over multiple runs. The
filter “add a file ID to the sequence ID” can be set to “add file ID
to sequence ID to identify original file” to add a file specific ID to
the sequence ID. This can be used to track from which original file
a specific sequence originates.
The immune repertoire pipeline
The immune repertoire pipeline is an extended version of the
previously published ImmunoGlobulinGalaxy (IGGalaxy) pipeline and
now allows the analysis of V(D)J gene usage, junction characteristics
and the diversity of the repertoire (9). BCR (IGH, IGK, IGL) as well as
TCR (TRA, TRB, TRD, TRG) data from up to 13 different species
can now be analyzed.
Input files. Three different input files can be used for the immune
repertoire pipeline: FASTA files, .txz files from IMGT/HighV-
QUEST (2), or output files from the SHM and CSR pipeline (see
below). The FASTA sequences do not contain information about
the CDR3 and V(D)J gene usage, and they will therefore be ana-
lyzed using IgBLAST and the corresponding BLAST database
(ftp://ftp.ncbi.nih.gov/blast/executables/igblast/release/) that have
been implemented in ARGalaxy (9). The .txz files from IMGT/
HighV-QUEST and output files from the SHM and CSR pipeline
already contain all the information provided by IMGT/HighV-
QUEST, and the relevant information for the immune repertoire
pipeline is extracted from the 11 IMGT/HighV-QUEST files (for
details on columns used see Supplemental Table I). The immune
repertoire pipeline allows simultaneous uploading of multiple
replicates from the same donor (as needed for analysis of the di-
versity) and multiple donors can be analyzed in parallel (Fig. 3B).
Filtering options. When analyzing IMGT/HighV-QUEST files,
multiple filtering steps are performed in the immune repertoire
pipeline to exclude sequencing reads where no rearrangement can
be found and to prevent overrepresentation of rearrangements due
to technical duplication and differences of RNA expression be-
tween cells (14). First, the pipeline only takes into account the best
matched V, D, and J gene as assigned by IMGT/HighV-QUEST.
FIGURE 1. Schematic overview of the ARGalaxy tool. ARGalaxy consists of four different parts (the demultiplex tool, the concatenate tool, the immune
repertoire pipeline, and the SHM and CSR pipeline) that can be run independently of, or in combination with, each other.
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Second, reads with “no results” as defined by IMGT/HighV-
QUEST are removed from the data (Fig. 3C). Third, dependent
on the research question, the “clonal type definition” filter can be
used to filter out duplicate rearrangements. A duplicate can be
defined based on the top V gene, the CDR3 nucleotide or amino
acid sequence in combination with the top J gene, D gene, or both.
The filter “remove the unproductive sequences from graphs” can
be used to include or remove unproductive rearrangements. Un-
productive rearrangements contain a stop codon or a frame shift
and are derived from DNA from B or T cells that underwent a
productive rearrangement on their second allele. These rear-
rangements have not been selected and therefore allow the user to
study the direct result of V(D)J recombination without the influ-
ence of selection. The junction analysis tables (see description
below) in the results section will always contain details on both
unproductive and productive sequences. Details on the basic steps
for sequence alignment and filtering when analyzing FASTA files
using IgBLAST are previously described (9).
Furthermore, the immune repertoire pipeline also allows you to
change the order of the V, D, and J genes used to visualize the data
in the “gene frequency” results tab (see description below). This
can be altered by changing the “order of V(D)J genes in graphs”
option to “user defined” and entering the preferred gene order.
This can be useful for visualizing the genes in order of their
chromosomal location. In the default setting the order of the V,
D, and J genes in the graphs will be based on the order of their
gene name.
The immune repertoire pipeline also allows the identification of
overlapping sequences between different replicates. The type of
calculation performed is dependent on the setting of the “shared
clonal types/clonality” filter. When only a single replicate is per-
formed no overlap can be determined (“do not determine over-
lap”). When multiple replicates are performed the number of
sequences that overlap between the replicates can be determined
(“determine the number of sequences that share the same clonal
type between the replicates”). When three or more replicates are
analyzed the “determine clonality of the donor” option allows the
calculation of the number of overlapping sequence and the clon-
ality score as described by Boyd et al. (25).
Data visualization. Upon analysis, the immune repertoire pipeline
shows the total number of sequences for each sample and the
number of productive and unproductive sequences that passed the
chosen filter settings (Fig. 3D). After entering the results section,
different tabs are shown with the various output data (Fig. 1). The
“gene frequency” tab shows the distribution of top V, D, and J
genes and gene families and gives information on the D-reading
frame usage. The “CDR3 characteristics” tab gives the median
and the distribution of CDR3 lengths and the amino acid usage in
the CDR3. Information on the combinations of V, D, and J genes
can be found in the “heatmaps” and the “circos” tabs (26). The
“compare heatmaps” tab can be used to compare heatmaps if
multiple donors are analyzed in parallel. Depending on the set-
tings of the “shared clonal types/clonality” filter and the number
of uploaded replicates, the “clonality” tab provides information on
the diversity of the repertoire and the number of overlapping se-
quences. Results of the analysis of the junctions (number of
nontemplated, palindromic, and deleted nucleotides) can be found
in the “junction analysis” tab. This tab is not shown when using
FASTA files as input files, because IgBLAST does not provide
information on the junction characteristics. Under the “down-
loads” tab all data used for the above-described graphs can be
found and downloaded for external analysis if needed. Details on
all calculations used for the results and graphs of the immune
repertoire pipeline can be found in Supplemental Table II.
The SHM and CSR pipeline
Input files. The SHM and CSR pipeline accepts IMGT/HighV-
QUEST .zip and .txz as input files, as IMGT provides the most
FIGURE 2. Additional information on the demultiplex tool. (A) Main page of the ARGalaxy tool. (B) Main page of the demultiplex tool. (C) Results page
of the demultiplex tool. (D) Data trimming is essential for the analysis of SHM frequency. SHM frequency in Ag-experienced B cells as analyzed using
untrimmed and 40-nt trimmed data is shown.
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complete data set regarding SHM (2). Upon running the SHM and
CSR pipeline, the relevant information on SHM is extracted from
the 11 output files present in the IMGT/HighV-QUEST output files
(Supplemental Table I), but the assignment of the subclasses and
clonal relationship is performed separately and is based on the
nucleotide sequences of the BCR rearrangements. When running
the SHM and CSR pipeline several filter settings can be chosen for
analysis (Fig. 4). All different filtering options are discussed below.
Quality filtering. The “sequence starts at” filter can be used to
exclude FR or CDR regions from analysis when the sequence does
not contain the complete VH gene, or when the VH primer is lo-
cated in one of the FR or CDR regions. Furthermore, the “sequence
starts at” filter also defines the region of the V gene that should be
present in the analyzed region, and incomplete sequences (se-
quences missing a gene region [e.g., FR1/CDR1] that should be
present) are removed from the analysis. Therefore setting this filter
correctly is very important to prevent unfairly excluding sequences.
Additionally, the pipeline automatically filters out sequences with
ambiguous bases (uncalled “n” bases) in the analyzed region.
Filtering options. The SHM and CSR pipeline allows several
options for data filtering on functionality and unique rearrange-
ments. The “functionality” filter allows filtering on productive
rearrangements, unproductive rearrangements, or both.
The “filter unique sequences” option allows the inclusion of
each unique sequence only once or the inclusion of only unique
sequences present twice or more for further analysis. In this case,
a unique sequence is defined by the nucleotide sequence of the
above-defined analyzed region and the constant gene. When
choosing the “remove uniques” option, first all sequences occur-
ring only once (based on the nucleotide sequence of the above-
analyzed regions) are removed. Afterward, all unique sequences
are selected based on the analyzed region in combination with the
subclass. Therefore, two sequences with the same nucleotide se-
quence but different subclasses will be both included in the
analysis. This option can be used to differentiate between true
SHM and sequencing errors as the likelihood of a sequencing error
occurring twice in the exact same location in the same sequence is
really small (27). When selecting the “keep unique” option, all
duplicates are removed based on the combination of the above-
selected region and the subclass. Selecting only unique sequences
prevents overrepresentation of certain clones due to amplification
biases. Additionally, or alternatively, the “remove duplicates bases
on” filter can be used to only include a single rearrangement per
clone. At this point, a clone can be identified based on the CDR3
sequence (amino acid or nucleotide) alone or in combination with
the top V gene, the C region, or both. An overview of all filtering
steps and their order are shown in Fig. 4B.
Subclass assignment. During analysis the SHM amd CSR pipeline
identifies human Cm, Ca, Cg, and Cε constant genes by a custom
script specifically designed for human (sub)class assignment in
repertoire data. In this script the reference sequences (Fig. 4C) for
the subclasses (NG_001019) are divided into 8-nt chunks that
FIGURE 3. Additional information on the concatenate tool and the immune repertoire pipeline. (A) Main page of the concatenate tool. (B) Main page of the
immune repertoire pipeline. (C) Flow chart with the filtering steps included in the immune repertoire pipeline. (D) Results page of the immune repertoire pipeline.
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overlap by 4 nt. These overlapping chunks are then individually
aligned in the right order to each input sequence. The percentage of
the chunks identified in each rearrangement is calculated in the
“chunk hit percentage.” The “chunk hit percentage” gives a good
separation between the Cm, Ca, Cg, and Cε genes, because they
have little sequence similarity. In contrast, the Ca and Cg sub-
classes are very homologous and only differ in a few nucleotides
(Fig. 4C). To assign subclasses, the “nt hit percentage” is calculated.
This percentage indicates how well the chunks covering the
subclass-specific nucleotides match with the different subclasses.
The “human class/subclass” filter can be used to define the strin-
gency of the filter. The most stringent filter for the subclass is 70%
“chunk hit percentage” and 70% “nt hit percentage,” which means
that at least 70% of the 8 nt chunks have to align with the class and
five out of seven subclass-specific nucleotides for Ca or six out of
eight subclass-specific nucleotides of Cg should match with the
specific subclass. When using a constant primer that results in a
shorter C sequences than the reference sequence (Fig. 4C), the
“chunk hit percentage” will be lower because not all of the refer-
ence sequence can be aligned and the subclass may not be assigned.
We have compared our custom script with blastn (https://blast.
ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=
BlastSearch&LINK_LOC=blasthome) using a dataset of 245
unique IGHG and IGHA rearrangements in which the subclass
was manually assigned. Our custom script correctly assigned all
245 IGH rearrangements, whereas blastn could not assign 3 of
the 245 IGH rearrangements.
Filtered IMGT/HighV-QUEST output files. If desired, additional
output files (one for each class) can be obtained that contain in-
formation on the sequences that passed the selected filtering cri-
teria. These files are in the same format as IMGT/HighV-QUEST
output files and therefore can be analyzed in the immune repertoire
pipeline or other analysis programs suitable for IMGT/HighV-
QUEST output files, such as IgAT (5).
Data visualization. Upon analysis, the SHM and CSR pipeline
gives information on the number and percentage of sequences after
each of the above described filtering steps. Subsequently, different
tabs can be opened that contain the results (Fig. 1).
The “SHM overview” tab provides information on the number
of sequences of the different (sub)classes. A table is included that
provides for each (sub)class the number of mutations, the number
of sequenced bases, and the average and median percentage of
SHM. Additionally, the number of transitions and transversions at
G/C and A/T locations and the amount of mutations located in
AID (RGYW/WRCY) or pol h (WA/TW) motives are shown.
Moreover, the number of replacement and silent mutations in both
the FR and CDR region are shown, and the total number of se-
quenced A, T, C, and G nucleotides are given in the table. Bar
graphs are included which visualize the percentage of mutations in
either the AID (RGYW/WRCY) or pol h (WA/TW) motives or the
relative and absolute number of mutations at A/T locations and
transition and transversion mutations at G/C locations (Fig. 1).
In the “SHM frequency” tab graphs can be found on the per-
centage of SHM. The “transition tables” tab provides detailed ta-
bles and visualization of the nucleotide transitions. Information on
the distribution of replacement mutations over the different amino
acid locations and the results of analysis of selection strength using
BASELINe (7) can be found in the “antigen selection” tab. The
FIGURE 4. Additional details on the SHM and CSR pipeline. (A) Main page of the SHM and CSR pipeline. (B) Flowchart showing the filtering steps
performed in the SHM and CSR pipeline. (C) Alignment of the nucleotide sequences encoding the different (sub)classes in the SHM and CSR pipeline. The
gray boxes indicate nucleotides that differ between subclasses.
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distribution of the sequences between the different subclasses is
visualized in the “CSR” tab. Information about the number and size
of clones in the analyzed sequences, as calculated using Change-O
(4), can be found in the “clonal relation” tab. Furthermore, this tab
also gives an overview table with the overlap of reads with the
same CDR1–CDR3 sequence but different subclasses. All data
used for making the different graphs and the results of clonal as-
signment as analyzed using Change-O can be found under the
“downloads” tab. Details of all calculations performed in the SHM
and CSR pipeline can be found in Supplemental Tables III and IV.
Applications of ARGalaxy
The Ag receptor repertoire can be studied for many different
reasons. In our laboratory, we have mainly analyzed repertoire
formation in healthy donors and patients with primary immuno-
deficiencies and/or autoimmunity. To illustrate the large number of
applications of this tool, we included some examples of patients
with alterations in their Ag receptor repertoire as analyzed using
ARGalaxy (Figs. 5, 6).
V, D, and J gene usage.One of the most frequently used parameters
to study the immune repertoire is to analyze the frequency of the V,
D, and J genes used. The frequency of these genes is not equal and
can change upon Ag selection. For example, analysis of IGH gene
frequency in naive and Ag-experienced B cells using ARGalaxy
shows reduced IGHV4-34 gene frequency in the Ag-experienced
repertoire (Fig. 5A).
Analysis of different V-D or V-J combinations can give infor-
mation about restriction or clonality of the repertoire and can be
FIGURE 5. Examples of patients with alterations in their Ag receptor repertoire as analyzed with the immune repertoire pipeline of ARGalaxy. (A)
Example of a healthy control that has reduced use of IGHV4-34 in the Ag-selected B cell repertoire, as compared with the naive B cell repertoire. (B)
Circos plots of VH-JH combinations of the Ag selected B cell repertoire of a chronic lymphoblastic leukemia (CLL) patient and a healthy control show
clonal expansion in the CLL patient. (C) CDR3 length of IGH rearrangements in Ag-selected B cells are shorter compared with the CDR3 length of naive B
cells of the same control. (D) CDR3 length distribution of IGH rearrangements in healthy controls and an XLF-deficient patient reveals reduced CDR3
length in the XLF patient. (E) Junction characteristics of naive B cell repertoire of healthy controls and patients with genetic defects in genes involved in V(D)J
recombination. ARTEMIS deficiency leads to more palindromic (P) nucleotides, whereas XLF, XRCC4, and LIG 4 deficiency leads to fewer nontemplated (N)
nucleotides. (F) Analysis of the diversity of the naive B cell repertoire shows reduced diversity in Nijmegen breakage syndrome (NBS) and AT patients.
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visualized in the immune repertoire pipeline with heatmaps or
circos plots (26). Fig. 5B shows a circos plot of VJ combinations
in the Ag-experienced B cell repertoire of a patient with chronic
lymphoblastic leukemia. In this case, a clear overrepresentation of
one VJ combination is found, compared with the large variety of
combinations found in the healthy donor.
CDR3 region. The CDR3 region is the most variable part of Ag
receptors and includes the junctional regions of the V, D, and J
genes. The average CDR3 length of the BCR repertoire decreases
after Ag exposure (Fig. 5C) (20, 28), and a long BCR CDR3 length
is associated with autoreactivity (28). The CDR3 region is also
often changed in patients with genetic defects in the V(D)J re-
combination process suffering from severe immunodeficiencies.
These defects can effect both the CDR3 length and the compo-
sition of the junctional regions. Patients with XLF deficiency have
a significantly shorter IGH CDR3 length compared with healthy
controls (Fig. 5D) (20). Additionally, the junctional region can
show alterations which are linked to their underlying genetic de-
fect (Fig. 5E). ARTEMIS deficiency results in increased numbers
of palindromic nucleotides, which are caused by defective opening
of the hairpins formed on the coding ends of the junctions. XLF,
XRCC4, and LIG4 form the ligation complex and genetic defects
in these genes result in decreased number of nontemplated nu-
cleotides (12, 13, 29, 30).
Diversity of the repertoire. The immune repertoire tool also allows
for the calculation of the diversity of the repertoire based on the
presence of unique rearrangements in independent PCRs as was
first described by Boyd et al. (25). Using ARGalaxy we have been
able to show reduced diversity of the naive B cell repertoire in
patients AT and Nijmegen breakage syndrome, which are both
DNA repair deficiencies (Fig. 5F) (14).
SHM. In the SHM and CSR pipeline different aspects of SHM can
be studied, including the median percentage of SHM. Analyzing
SHM in IGA transcripts of an ARTEMIS-deficient patient and four
age-matched healthy controls reveals reduced SHM in the
ARTEMIS-deficient patient as previously described (Fig. 6A) (10).
Detailed analysis of the patterns of SHM can give insight into the
repair pathways used to introduce SHM. UNG deficiency, for
example, results in a reduction of transitions mutations at G/C
base pair due to a block in base excision repair (Fig. 6B).
CSR. Finally, CSR can also be affected by genetic defects in DNA
repair or in patients that lack sufficient T cell help. For example,
patients with AT have an increased frequency of IGG1 and IGG3
transcripts (Fig. 6C) (15).
Discussion
ARGalaxy is a user-friendly, open-source tool that allows fast and
easy analysis of the complete immune repertoire. This tool is
unique, as it provides both general information on V, D, and J gene
usage, junction characteristics, and diversity in the immune rep-
ertoire pipeline, and detailed information about SHM, Ag selection,
clonality, and CSR in the SHM and CSR pipeline. Open-source
tools on Ag receptor data were implemented in ARGalaxy to
make the analysis of Ag receptor data complete and fast. In the
present study we described the set-up and workflow of ARGalaxy
and included several clinical examples to illustrate its functionality,
which focused on the field of primary immunodeficiencies.
However, ARGalaxy is also applicable to many other patient
groups such as autoimmune diseases, allergy, and leukemia. Ad-
ditionally, it can be applied to more basic research questions such as
the investigation of differences in repertoire between B cell subsets.
ARGalaxy extracts information from IMGT/HighV-QUEST
output files. A similar tool that extracts information from these
files is IgAT (5). This is a Microsoft Excel–based tool that can be
used to analyze BCR L and H chain rearrangements, and it also
visualizes V, D, and J gene usage, CDR3 and junction character-
istics, and frequency of SHM. ARGalaxy complements IgAT be-
cause it provides analysis of both BCR and TCR rearrangement
and importantly provides filtering of the immune repertoire data,
which increases the reliability of the data. Additionally, the SHM
and CSR pipeline provides additional information on the SHM
patterns and the subclass distribution. Because IgAT also provides
supplemental information to ARGalaxy, the filtered IMGT output
files can be used to run IgAT on the filtered dataset to complete the
detailed analysis of the immune repertoire.
When analyzing repertoire data using ARGalaxy, it is important
to remove all adaptors, barcodes (such as multiplex identifier se-
quences), or primer sequences from all sequences before analysis in
IMGT/HighV-QUEST. Depending on the primer location, IMGT/
HighV-QUEST will include these regions in the alignment and
therefore any stop codons in these regions lead to assignment of
productive sequences as unproductive. Additionally, all mis-
matches in these regions will be assigned as SHM, which will
significantly increase SHM levels in the analysis. Alternatively, the
effect on the levels of SHM can be prevented by excluding the
primers binding region and any regions upstream using the “se-
quence starts at” filter in the SHM and CSR pipeline. This,
however, will not prevent the wrongful assignment of unproduc-
tive sequences.
The immune repertoire pipeline allows for basic data filtering to
prevent overrepresentation of rearrangements due to amplification
biases. In the SHM and CSR pipeline more advanced filtering
options are included to allow better discrimination between se-
quencing errors and SHM. These filtering steps are not included in
the immune repertoire pipeline, as single nucleotide differences are
expected to have a very limited effect in assignment of V, D, or J
genes. However, when combining the analysis of SHM or CSRwith
the analysis of V, D, and J segment usage it might be preferential to
do both analyses on the exact same rearrangements. To allow for
this, we have included the option in the SHM and CSR pipeline to
create an output file with all rearrangements that passed the chosen
FIGURE 6. Examples of Ag-experienced B cell repertoire in patients with altered SHM or CSR. (A) Analysis of SHM levels in an ARTEMIS-deficient
patients and four age-matched healthy controls reveals reduced SHM in the ARTEMIS patient. (B) Analysis of SHM patterns shows that the UNG-deficient
patient has reduced numbers of transversions at GC locations. (C) The distribution of transcripts between the different subclasses in two AT patients shows
increased IGG1 transcripts in AT patients as compared with age-matched healthy controls.
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filter settings. This output file can then be analyzed using the
immune repertoire pipeline.
When analyzing SHM it is essential to be able to distinguish
between sequencing errors and true SHM. To limit the effect of
sequencing errors in the analysis of BCR repertoire data, we have
included several additional filters to the SHM and CSR pipeline.
This includes the removal of incomplete sequences or sequences
containing an ambiguous base as automatically performed by the
SHM and CSR pipeline. Additionally, the “only include se-
quences present twice or more” option in the “filter unique se-
quences” filter allows the inclusion of only unique sequences of
which the exact same CDR1–CDR3 sequence occurs twice or
more in the data. When using this setting it is important to re-
alize that multiple sequences from a single clone are still in-
cluded. In most cases this does not cause any problems, as data
are often limited in their clonality. However, it is important to
check for clonality of your data during analysis, as the presence of
dominant clones can cause major skewing of the results. To prevent
the presence of clonally related sequences in the filtered data the
“remove duplicates bases on” filter can be applied to only include a
single sequence per clone.
ARGalaxy was originally developed for the analysis of the
human immune repertoire. However, as the format of the output
files from IMGT/HighV-QUEST is the same for all species, it is
also possible to analyze repertoire data from all other species
implemented in IMGT/HighV-QUEST. The only limitation in the
analysis of other species is the subclass assignment in the SHM and
CSR pipeline, as our algorithm is specifically developed for
assigning human (sub)classes. To prevent subclass assignment, we
have added the “do not assign (sub)class” option in the SHM and
CSR pipeline, which should be selected in the “human class/
subclass” filter to prevent incorrect (sub)class assignment when
analyzing nonhuman samples. Additionally, this option should be
selected when analyzing BCR L chain data or BCR H chain data
in which the (sub)class-specific sequence is absent.
In the SHM and CSR pipeline we have built in Change-O (4), a
tool that allows the analysis of clonal relationship between se-
quences. In our pipeline this tool is applied to all sequences that
have passed the chosen filter settings. Depending on the chosen
filter settings, the results of Change-O will be only representative
of the clonality within the filtered data and not the original
sample. When the “filter unique sequences” or the “remove du-
plicates bases on” filter is applied, duplicate sequences are re-
moved and therefore the clonality of the data does not represent
the clonality of the original sample. Additionally, a high number
of PCR cycles used to amplify the BCR rearrangements can cause
nonlinear amplification of the input material, and therefore
skewing of the clonality in the data as compared with the original
material.
In conclusion, in this study we present ARGalaxy, a novel tool that
allows the analysis of the complete immune repertoire of different
species. This tool will be valuable for analysis of the immune rep-
ertoire in different research fields to gain more insight into the de-
velopment of Ag-selected repertoire in health and disease.
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